In addition, in breast and thyroid cancers, we also found that COMP was positively associated with other EMT markers (TWIST1, TWIST2, SNAI1, SNAI2, DDR2, MMP2, MMP9, FN1, VIM) and estrogen receptor-α (ESR1) (Figures 6M–O). This evidence concerns the gene COMP and thyroid gland carcinoma.